Sec. 105.

148 words·~1 min read·/bill/114/s/2843/is/section-105·

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

Section 319F–2(c)(1)(B) of the Public Health Service Act (42 U.S.C. 247d–6b(c)(1)(B)) is amended— in clause (i)(III)(bb), by striking ; or and inserting a semicolon; in clause (ii), by striking the period and inserting ; or ; and by adding the following new clause: the Secretary determines to be a necessary countermeasure to diagnose, mitigate, prevent, or treat harm from any infectious disease that may pose a threat to the public health; and is approved or cleared under chapter V of the Federal Food, Drug, and Cosmetic Act, or licensed under section 351 of this Act; or is a countermeasure for which the Secretary determines that sufficient and satisfactory clinical experience or research data (including data, if available, from pre-clinical and clinical trials) support a reasonable conclusion that the countermeasure will qualify for approval or licensing within 10 years after the date of a determination under subclause (I). .

Connections1 off-index

1 reference not yet in our index

42 USC 247d–6b(c)(1)(B)

Citation graph

cites case law

Sec. 105

Cite42 USC 247d–6b(c)(1)(B)

Cites 1Cited by 0 across 0 sources